[HTML][HTML] HPV and cervical cancer: A review of epidemiology and screening uptake in the UK

S Choi, A Ismail, G Pappas-Gogos, S Boussios - Pathogens, 2023 - mdpi.com
Cervical cancer is the fourth most common malignancy in females worldwide, and a leading
cause of death in the United Kingdom (UK). The human papillomavirus (HPV) is the …

HPV infection and cervical disease: a review

JR Carter, Z Ding, BR Rose - Australian and New Zealand …, 2011 - Wiley Online Library
Cervical cancer remains a significant problem worldwide particularly in underdeveloped
countries. The disease and its financial impact are significant. Infection with the human …

Natural history and epidemiology of HPV infection and cervical cancer

X Castellsagué - Gynecologic oncology, 2008 - Elsevier
Cervical cancer is the most common cancer affecting women in developing countries. It has
been estimated to have been responsible for almost 260 000 deaths annually, of which …

Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination—review of current perspectives

CK Chan, G Aimagambetova, T Ukybassova… - Journal of …, 2019 - Wiley Online Library
Viral infections contribute as a cause of 15–20% of all human cancers. Infection by
oncogenic viruses can promote different stages of carcinogenesis. Among many types of …

[PDF][PDF] Human papillomavirus and cervical cancer: burden of illness and basis for prevention

H Trottier, EL Franco - Am J Manag Care, 2006 - ptce.s3.amazonaws.com
Genital infection with human papillomaviruses (HPV) is one of the most common sexually
transmitted conditions. The central causal role in cervical carcinogenesis of the so-called …

[HTML][HTML] Towards the global elimination of cervical cancer

K Canfell - Papillomavirus research, 2019 - Elsevier
Two very effective prevention strategies for cervical cancer exist–vaccination against the
human papillomavirus (HPV) and cervical screening with primary HPV testing followed by …

[HTML][HTML] HPV and cervical cancer: screening or vaccination?

FX Bosch, X Castellsague, S De Sanjosé - British journal of cancer, 2008 - nature.com
Following the demonstration of the superior validity of human papillomavirus (HPV) tests in
screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines …

[HTML][HTML] Cancer cervix: Epidemiology and disease burden

S Pimple, G Mishra - Cytojournal, 2022 - ncbi.nlm.nih.gov
Cervical cancer remains a major public health problem, ranking as the fourth most common
cause of cancer incidence and mortality in women worldwide. Wide variations in cervical …

Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention

SM Garland, JML Brotherton, SR Skinner, M Pitts… - Vaccine, 2008 - Elsevier
The region encompassing Australasia and Oceania, including Australia, New Zealand, Fiji
and Papua New Guinea, is a diverse one with respect to ethnicities, cultures and …

HPV infection in Europe

H De Vuyst, G Clifford, N Li, S Franceschi - European journal of cancer, 2009 - Elsevier
In order to estimate the impact of primary cervical cancer screening with human
papillomavirus (HPV) testing, and implementation of the current HPV vaccines, we have …